This report provides a comprehensive analysis of the Global Foot And Mouth Disease Vaccine Market, including historical market sizes from 2019 to 2022 and forecasts for 2024 to 2031. The market is estimated to be valued at USD 2.50 Billion in 2023 and is projected to grow to approximately USD 5.23 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.95% during the forecast period. This growth underscores the increasing demand for advanced data management solutions and highlights the importance of technological innovations in the sector.
The Foot And Mouth Disease Vaccine (FMD) market focuses on vaccines designed to protect livestock, particularly cattle, pigs, sheep, and goats, from the highly contagious viral infection known as foot and mouth disease. This disease poses a significant threat to livestock health, leading to severe economic losses in the agriculture sector due to reduced productivity and trade restrictions. The market is driven by increasing awareness of disease management and prevention, as well as government initiatives to control outbreaks. Advances in vaccine technology have led to the development of more effective and safer vaccines, enhancing their acceptance among farmers and veterinarians. Overall, the FMD vaccine market plays a crucial role in safeguarding livestock health and ensuring food security worldwide.
The Foot And Mouth Disease Vaccine market is driven by increasing R&D efforts in animal healthcare and the regular outbreaks of FMD, which highlight the urgent need for effective vaccination. Government-led initiatives and regulations further support vaccine development and distribution to control the disease. However, the market faces challenges due to a strict regulatory landscape that can delay approvals and increase costs. Opportunities exist for innovation in vaccine formulations and delivery methods to enhance efficacy and accessibility in livestock management.
For the geography segment, regional supply, demand, major players, and price are presented from 2019 to 2031. This report covers the following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
By Animal Type:
Cattle
Pig
Sheep and Goat
Others
The animal vaccines market is segmented by animal type, including cattle, pigs, sheep and goats, and others. Cattle vaccines are crucial for protecting livestock against common diseases that can affect dairy and meat production. Pig vaccines focus on diseases that impact swine health and productivity, while vaccines for sheep and goats address specific health issues in small ruminants. This segmentation allows for targeted vaccine development tailored to the unique needs of different animal species.
By Vaccine Type-
Conventional Vaccines
Oil-Based Vaccines
Aluminum hydroxide/saponin-based Vaccines
Emergency Vaccines
This market categorizes vaccines into conventional vaccines, oil-based vaccines, aluminum hydroxide/saponin-based vaccines, and emergency vaccines. Conventional vaccines are widely used for routine immunizations, while oil-based vaccines provide longer-lasting immunity and are effective against various pathogens. Aluminum hydroxide and saponin-based vaccines enhance immune responses, making them suitable for certain diseases. Emergency vaccines are developed for outbreak situations, enabling rapid response to disease threats.
By Distribution Channel:
Veterinary hospitals & clinics
Government institutions
Retail pharmacies
Online pharmacies
The distribution of animal vaccines occurs through veterinary hospitals and clinics, government institutions, retail pharmacies, and online pharmacies. Veterinary hospitals and clinics serve as primary sources for vaccine administration, ensuring professional oversight. Government institutions often facilitate public health initiatives and vaccination programs for livestock. Retail and online pharmacies provide accessible options for farmers and animal owners, enhancing the availability of vaccines across different regions. This diverse distribution network ensures efficient vaccine delivery to the end-users.
Key Players:
Merck & Co., Inc.
Zoetis Inc.
Boehringer Ingelheim International GmbH
Indian Immunologicals Limited
Hester Biosciences Limited
Brilliant Bio Pharma Limited
Biovet Private Ltd
Biog nesis Bag
Vetal Animal Health Products Inc.
Indian Veterinary Research Institute (IVRI)
For the competitor segment, the report includes global key players of the Foot And Mouth Disease Vaccine Vaccine Vaccine Market as well as some small players. The information for each competitor includes:
Company Profile
Main Business Information
Financial Analysis
Market Share
Please ask for sample pages for the full company list
Base Year: 2023
Historical Data: from 2019 to 2022
Forecast Data: from 2024 to 2031
Any special requirements about this report, please let us know and we can provide a custom report.
TABLE OF CONTENTS
Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. RA Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Market Overview
3.1.1.Foot And Mouth Disease Vaccine Outlook
3.1.2.Foot And Mouth Disease Vaccine Overview
3.2. Macro-Economic Overview
3.2.1. GDP Growth
3.2.2. Retail Industry Growth
3.3. Pricing Analysis
3.4. Challenges related to the adoption of Foot And Mouth Disease Vaccine
3.5. Regulations of Foot And Mouth Disease Vaccine
3.6. Forecast Factors: Relevance and Impact
3.7. Market Dynamics
3.7.1. Drivers
3.7.2. Restraints
3.7.3. Opportunity
3.7.4. Trends
3.7.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y-o-Y Projections
4.4. Absolute Opportunity Analysis
5. Global Foot And Mouth Disease Vaccine Analysis by Technology
5.1. Introduction
5.1.1. Market Value Share Analysis By Technology
5.1.2. Y-o-Y Growth Analysis By Technology
5.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Technology
5.3. Market Attractiveness Analysis by Technology
6. Global Foot And Mouth Disease Vaccine Analysis By Application
6.1. Introduction
6.1.1. Market Value Share Analysis By Application
6.1.2. Y-o-Y Growth Analysis By Application
6.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Application
6.3. Market Attractiveness Analysis By Application
7. Market Structure Analysis
7.1. Market Analysis by Tier of Companies
7.2. Market Concentration
8. Competition Analysis
8.1. Competition Dashboard
8.2. Company Profiles (15 Companies)
8.2.1 Merck & Co.,Inc.
8.2.1.1. Overview
8.2.1.2. Technology Portfolio
8.2.1.3. Financial Overview
8.2.2. Zoetis Inc.
8.2.2.1. Overview
8.2.2.2. Technology Portfolio
8.2.2.3. Financial Overview
8.2.3. Boehringer Ingelheim International GmbH
8.2.3.1. Overview
8.2.3.2. Technology Portfolio
8.2.3.3. Financial Overview
8.2.4. Indian Immunologicals Limited
8.2.4.1. Overview
8.2.4.2. Technology Portfolio
8.2.4.3. Financial Overview
8.2.5. Hester Biosciences Limited
8.2.5.1. Overview
8.2.5.2. Technology Portfolio
8.2.5.3. Financial Overview
8.2.6. Brilliant Bio Pharma Limited
8.2.6.1. Overview
8.2.6.2. Technology Portfolio
8.2.6.3. Financial Overview
8.2.7. Biovet Private Ltd
8.2.7.1. Overview
8.2.7.2. Technology Portfolio
8.2.7.3. Financial Overview
8.2.8. Biogénesis Bagó
8.2.8.1. Overview
8.2.8.2. Technology Portfolio
8.2.8.3. Financial Overview
8.2.9. Vetal Animal Health Products Inc.
8.2.9.1. Overview
8.2.8.2. Technology Portfolio
8.2.9.3. Financial Overview
8.2.10. Indian Veterinary Research Institute (IVRI)
8.2.10.1. Overview
8.2.10.2. Technology Portfolio
8.2.10.3. Financial Overview
8.2.11. Company11
8.2.11.1. Overview
8.2.11.2. Technology Portfolio
8.2.11.3. Financial Overview
8.2.12. Company12
8.2.12.1. Overview
8.2.12.2. Technology Portfolio
8.2.12.3. Financial Overview
8.2.13. Company13
8.2.13.1. Overview
8.2.13.2. Technology Portfolio
8.2.13.3. Financial Overview
8.2.14. Company14
8.2.14.1. Overview
8.2.14.2. Technology Portfolio
8.2.14.3. Financial Overview
8.2.15. Company15
8.2.15.1. Overview
8.2.15.2. Technology Portfolio
8.2.15.3. Financial Overview
9. Global Foot And Mouth Disease Vaccine Analysis By Region
9.1. Introduction
9.1.1. Market Value Share Analysis By Region
9.1.2. Y-o-Y Growth Analysis By Region
9.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Region
9.2.1. North America
9.2.2. Middle East and Africa
9.2.3. South America
9.2.4. Asia-Pacific
9.2.5. Others
9.3. Current Market Size (USD Mn) Forecast 2023-2030 By Region
9.3.1. North America
9.3.2. Middle East and Africa
9.3.3. South America
9.3.4. Asia-Pacific
9.3.5. Others
9.4. Market Attractiveness Analysis By Region
10. North America Foot And Mouth Disease Vaccine Analysis
10.1. Introduction
10.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Rest of North America
10.3. Current Market Size (USD Mn) Forecast 2023-2030 By Country
10.3.1. U.S.
10.3.2. Canada
10.3.3. Mexico
10.3.4. Rest of North America
10.4. Historical Market Size (USD Mn) Analysis 2018-2022 By Technology
10.5. Current Market Size (USD Mn) Forecast 2023-2030 By Technology
10.6. Historical Market Size (USD Mn) Analysis 2018-2022 By Application
10.7. Current Market Size (USD Mn) Forecast 2023-2030 By Application
11. South America Foot And Mouth Disease Vaccine Analysis
11.1. Introduction
11.2. Regional Pricing Analysis
11.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of South America
11.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America
11.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Technology
11.6. Current Market Size (USD Mn) Forecast 2023-2030 By Technology
11.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Application
11.8. Current Market Size (USD Mn) Forecast 2023-2030 By Application
12. Europe Foot And Mouth Disease Vaccine Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
12.3.1. Germany
12.3.2. Italy
12.3.3. France
12.3.4. Spain
12.3.5. U.K.
12.3.6. Rest of Europe
12.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
12.4.1. Germany
12.4.2. Italy
12.4.3. France
12.4.4. Spain
12.4.5. U.K.
12.4.6. Rest of Europe
12.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Technology
12.6. Current Market Size (USD Mn) Forecast 2023-2030 By Technology
12.7. Historical Market Size (USD Mn) Analysis 2018-2022 By Application
12.8. Current Market Size (USD Mn) Forecast 2023-2030 By Application
13. Middle East and Africa Foot And Mouth Disease Vaccine Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
13.3.1. Saudi Arabia
13.3.2. U.A.E.
13.3.3. South Africa
13.3.4. Turkey
13.3.5. Rest of Middle East and Africa
13.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
13.4.1. Saudi Arabia
13.4.2. U.A.E.
13.4.3. South Africa
13.4.4. Turkey
13.4.5. Rest of Middle East and Africa
14. Asia-Pacific Foot And Mouth Disease Vaccine Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
14.3.1. China
14.3.2. India
14.3.3. Japan
14.3.4. South Korea
14.3.5. Singapore
14.3.6. Australia and New Zealand
14.3.7. Rest of Asia-Pacific
14.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
14.4.1. China
14.4.2. India
14.4.3. Japan
14.4.4. South Korea
14.4.5. Singapore
14.4.6. Australia and New Zealand
14.4.7. Rest of Asia-Pacific
i. Research Methodology
ii. Assumptions & Acronyms
LIST OF FIGURES
Figure 01: Global Molecular Methods For Food Safety Testing, BPS Analysis, By Technology, 2018(H), 2023(E) & 2030(F)
Figure 02: Global Molecular Methods For Food Safety Testing, Y-O-Y Growth, By Technology, 2020(A) - 2030(F)
Figure 03: Global Foot And Mouth Disease Vaccine Attractiveness Analysis, By Technology (2020)
Figure 04: Global Molecular Methods For Food Safety Testing, BPS Analysis, By Application, 2018(H), 2023(E) & 2030(F)
Figure 05: Global Molecular Methods For Food Safety Testing, Y-O-Y Growth, By Application, 2018(H) - 2030(F)
Figure 06: Global Foot And Mouth Disease Vaccine Attractiveness Analysis, By Application
Figure 07: Global Molecular Methods For Food Safety Testing, Value Analysis, By Technology, 2018(H)-2030(F)
Figure 08: Global Molecular Methods For Food Safety Testing, Value Analysis, by Application, 2018(H)-2030(F)
Figure 09: Global Molecular Methods For Food Safety Testing, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global Molecular Methods For Food Safety Testing, Y-O-Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global Foot And Mouth Disease Vaccine Attractiveness Analysis, by Region
Figure 12: North America Foot And Mouth Disease Vaccine Value (USD Mn Forecast, 2018 – 2022
Figure 13: North America Foot And Mouth Disease Vaccine Value (USD Mn Forecast, 2023 – 2030
Figure 14: South America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, 2018 – 2022
Figure 15: South America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, 2023 – 2030
Figure 16: Europe Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, 2018 – 2022
Figure 17: Europe Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, 2023 – 2030
Figure 18: Middle East and Africa Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, 2018 – 2022
LIST OF TABLES
Table 01: Global Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Technology, 2018(H) – 2030(F)
Table 02: Global Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Application, 2018(H) – 2030(F)
Table 03: Global Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 04: North America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 05: North America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Technology, 2018(H) – 2030(F)
Table 06: North America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Application, 2018(H) – 2030(F)
Table 07: South America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 08: South America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Technology, 2018(H) – 2030(F)
Table 09: South America Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Application, 2018(H) – 2030(F)
Table 10: Europe Foot And Mouth Disease Vaccine Value (USD Mn) and Forecast, by Country, 2018(H) – 2030(F)
Table 11: Europe Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Technology, 2018(H) – 2030(F)
Table 12: Europe Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Application End-user, 2018(H) – 2030(F)
Table 13: Middle East and Africa Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 14: Middle East and Africa Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Technology, 2018(H) – 2030(F)
Table 15: Middle East and Africa Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Application, 2018(H) – 2030(F)
Table 16: Asia-Pacific Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 17: Asia-Pacific Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Technology, 2018(H) – 2030(F)
Table 18: Asia-Pacific Foot And Mouth Disease Vaccine Value (USD Mn) Forecast, By Application, 2018(H) – 2030(F)
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Stats And Research ™ Copyright © 2024 .